1.
Simpson E, Yosipovitch G, Eyerich K, Staumont-Sallé D, Shahriari M, Gallo G, Wolf E, Pierce E, Liu C, Zhong J, Agell H, de Bruin-Weller M. Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023Nov.13 [cited 2024Jul.15];7(6):s279. Available from: https://jofskin.org/index.php/skin/article/view/2389